| Product Name |
Mounjaro (Tirzepatide) Injection 10mg |
| Brand |
Eli Lilly and Company |
| Dosage |
10 mg / 0.5 mL — subcutaneous injection, once weekly |
| Description |
Mounjaro (tirzepatide) 10mg is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, and for chronic weight management in adults with obesity or overweight with at least one weight-related condition. The 10mg dose is reached by escalation through lower doses. Clinical trials have shown average weight loss of 7.5 to 10.7 kg at the 10mg dose. Administered as a once-weekly subcutaneous injection. |
| Special Ingredients |
|
| Ingredients (All) |
|
| Categories |
GLP-1 Support & Weight Management |
| Disclaimer |
| Longevity Health Co. does not provide medical advice. Customers are advised to consult a licensed healthcare professional before starting any supplement or prescription medication. Products requiring medical supervision should only be used under the guidance of a qualified healthcare professional. |
